Media Pack
News

Current Edition

Volume 16 Issue 1
 
Uncategorized

Local Medical Monitoring in Russia is Integral to Overall Study Success

Local Medical Monitoring in Russia is Integral to Overall Study Success For more than a decade now, Russia has proven to be a promising geography for conducting clini...
30 November 2012 Uncategorized
Continue Reading →
Are Clinical Trials Agile Enough? What Pharma can Learn from Software Development
Uncategorized

Are Clinical Trials Agile Enough? What Pharma can Learn from Software Development

Are Clinical Trials Agile Enough? What Pharma can Learn from Software Development With product development life-cycles often in excess of 10 years, drug developers m...
30 November 2012 Uncategorized
Continue Reading →
Uncategorized

Soothing the Logistical Headache of Clinical Trials

Soothing the Logistical Headache of Clinical Trials As many as 30% of subjects taking part in Phase III clinical studies drop out of such studies. Gruelling schedules...
30 November 2012 Uncategorized
Continue Reading →
Uncategorized

Leveraging Cold Chain Management to Improve Clinical Trial Efficiency

Leveraging Cold Chain Management to Improve Clinical Trial Efficiency The renewed investment in product development has been accompanied by formidable challenges for ...
30 November 2012 Uncategorized
Continue Reading →
Uncategorized

Getting Results with eLearning

Getting Results with eLearning In a pharma clinical department or a CRO, there may well be groups of staff, perhaps in worldwide locations, who need to be trained qui...
30 November 2012 Uncategorized
Continue Reading →
Prevention of Cardiovascular Disease with Omega-3 Polyunsaturated Fatty Acids
Uncategorized

Prevention of Cardiovascular Disease with Omega-3 Polyunsaturated Fatty Acids

Prevention of Cardiovascular Disease with Omega-3 Polyunsaturated Fatty Acids Large-scale epidemiological studies and recent clinical studies have demonstrated that i...
30 November 2012 Uncategorized
Continue Reading →
Uncategorized

A New Era in Alzheimer’s Research

A New Era in Alzheimer's Research There's a lot at stake for Alzheimer's research and development.  Importantly the first product to market which claims disease-modif...
30 November 2012 Uncategorized
Continue Reading →
Uncategorized

Potential Therapeutic Properties of Human Mesenchymal Stem Cells

Potential Therapeutic Properties of Human Mesenchymal Stem Cells The ability of embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and multipotent c...
30 November 2012 Uncategorized
Continue Reading →
Clinical Trials in Ukraine – Recent Changes
Uncategorized

Clinical Trials in Ukraine – Recent Changes

Clinical Trials in Ukraine - Recent Changes Recently -adopted amendments to the Ministry of Health of Ukraine order regulating clinical trials introduced significant ...
30 November 2012 Uncategorized
Continue Reading →
Uncategorized

What exactly is Health 2.0?

Pascal Lardier, Director International Events of Health 2.0, answers questions about the co-production of health by patients and physicians today and in the future. O...
12 October 2012 Uncategorized
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte